Can-Fite BioPharma American Depositary Shares
CANF
9 hedge funds and large institutions have $159K invested in Can-Fite BioPharma American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
13% more funds holding
Funds holding: 8 → 9 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
69% less capital invested
Capital invested by funds: $518K → $159K (-$359K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$36.3K |
| 2 |
Mercer Global Advisors
Denver,
Colorado
|
+$28.8K |
| 3 |
Renaissance Technologies
New York
|
+$27.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$24.6K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$4.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$392K |
| 2 |
VF
Virtu Financial
New York
|
-$38K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$20K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SFI
1
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $31K | +$36.3K | +87 | New |
|
|
2
Envestnet Asset Management
Chicago,
Illinois
| $25K | +$4.17K | +10 | +16% |
|
|
VF
3
Virtu Financial
New York
| $24K | -$38K | -91 | -57% |
|
|
4
Mercer Global Advisors
Denver,
Colorado
| $24K | +$28.8K | +69 | New |
|
|
5
Renaissance Technologies
New York
| $23K | +$27.1K | +65 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $21K | +$24.6K | +59 | New |
|
7
Morgan Stanley
New York
| $9K | +$2.5K | +6 | +32% |
|
|
GWM
8
Geneos Wealth Management
Englewood,
Colorado
| $1K | +$1.25K | +3 | New |
|
|
FDCDDQ
9
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $943 | – | – | – |
|
|
CH
10
CVI Holdings
Wilmington,
Delaware
| – | -$392K | -990 | Closed |
|
|
TSS
11
Two Sigma Securities
New York
| – | -$20K | -50 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$6K | -15 | Closed |
|
|
PAG
13
Private Advisor Group
Morristown,
New Jersey
| – | -$4K | -10 | Closed |
|
CANF Hedge Fund Activity: Q3 2020 in Review
9 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q3 2020, worth a combined $159K — down 69% from $518K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CANF positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna Fundamental Investments, opening a new position worth an estimated $36.3K. The largest seller was CVI Holdings, exiting entirely with an estimated $392K sold.
- 9 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q3 2020, up from 8 in Q2 2020.
- Funds reported $159K of Can-Fite BioPharma American Depositary Shares stock for Q3 2020, down 69% quarter-over-quarter.
- 5 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q3 2020 and 4 closed out, a net change of +1 holder.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q3 2020 was Susquehanna Fundamental Investments, an estimated $36.3K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q3 2020 was CVI Holdings, an estimated $392K sold.
Based on aggregated 13F filings for Q3 2020.